Table 4.
Cholesterol-Lowering and Obesity-Preventing Effects | |
---|---|
Reduction of TC, LDL-C, ApoB levels | [9] |
Improvement of lipoprotein profile and inhibition of LDL-C oxidation | [42] |
Reduction of body adiposity, body mass index, and body weight | [77] |
Cardioprotective effects | |
Reduction of atherogenic index | [80] |
Reduction of blood pressure | [81] |
Antidiabetic effects | |
Reduction of blood glucose level via GLP-1 production | [82] |
Reduction of carbohydrate absorption | [83] |
Reduction of insulin resistance in diabetic patients | [84] |
Hepatoprotective effects | |
Reduction of serum ALT, AST, and GGT levels | [40,85] |
Induction of liver antioxidant enzymes: SOD, GPx, CAT | [40] |
Neuroprotective effects | |
Alzheimer-preventing mechanisms: anxiolytic, sedative, and memory-enhancing properties | [9,86] |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; CAT: catalase; GGT: gamma-glutamyl transferase; GLP-1: glycoprotein 1; GPx: glutathione peroxidase; LDL-C: low-density lypoprotein cholesterol; SOD: superoxide dismutase; TC: total cholesterol.